Jianpeng Yu, Ph.D.

Targeted radiopharmaceuticals have become of widespread interest in the scientific community given their ability to detect and treat metastatic disease. We aim to validate the use of novel chelate-tethered eHSP-90 inhibitors as potential agents for detection...